BMIPP SPECT in cardiac sarcoidosis: A marker of risk?
- PMID: 33904149
- DOI: 10.1007/s12350-021-02626-6
BMIPP SPECT in cardiac sarcoidosis: A marker of risk?
Erratum in
-
Correction to: BMIPP SPECT in cardiac sarcoidosis: A marker of risk?J Nucl Cardiol. 2021 Aug;28(4):1760. doi: 10.1007/s12350-021-02669-9. J Nucl Cardiol. 2021. PMID: 34036531 No abstract available.
References
-
- Slart RHJA, Glaudemans AWJM, Lancellotti P, Hyafil F, Blankstein R, Schwartz RG, et al. A joint procedural position statement on imaging in cardiac sarcoidosis: From the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology. J Nucl Cardiol 2018;25:298-319. - DOI
-
- Bois JP, Muser D, Chareonthaitawee P. PET/CT evaluation of cardiac sarcoidosis. PET Clin 2019;14:223-32. - DOI
-
- Wiefels C, Lamai O, Kandolin R, Birnie D, Leung E, Tinoco Mesquita C, et al. The role of 18F-FDG-PET/CT in cardiac sarcoidosis. Int J Cardiovasc Sci 2020;33:389-400.
-
- Trivieri MG, Spagnolo P, Birnie D, Liu P, Drake W, Kovacic JC, et al. Challenges in cardiac and pulmonary sarcoidosis. J Am Coll Cardiol 2020;76:1878-901. - DOI
-
- Bravo PE, Singh A, Di Carli MF, Blankstein R. Advanced cardiovascular imaging for the evaluation of cardiac sarcoidosis. J Nucl Cardiol 2019;26:188-99. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical